Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02586038
What this trial is testing

STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS

Who this might be right for
Multiple Myeloma
Mario Boccadoro 175
Testing effectiveness (Phase 2)WithdrawnNCT00081055
What this trial is testing

OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Mesoblast International Sàrl
Testing effectiveness (Phase 2)Ended earlyNCT04692155
What this trial is testing

Clinical Trial of Ublituximab and Umbralisib With CHOP (U2-CHOP) Followed by U2 Maintenance (U2-CHOP-U2) in Previously Untreated Mantle Cell Lymphoma (MCL)

Who this might be right for
Mantle Cell Lymphoma
University of Alabama at Birmingham 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07398638
What this trial is testing

Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Sun Yat-sen University 122
Not applicableUnknownNCT06058858
What this trial is testing

Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis

Who this might be right for
Cytomegalovirus InfectionsAcute LeukemiaB Cell Lymphoma
Assistance Publique - Hôpitaux de Paris 250
Large-scale testing (Phase 3)Active Not RecruitingNCT06970743
What this trial is testing

BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeOne Medicines 153
Not applicableTemporarily pausedNCT06639958
What this trial is testing

Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home

Who this might be right for
Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia
Children's Oncology Group 64
Large-scale testing (Phase 3)Looking for participantsNCT07377578
What this trial is testing

Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD. 394
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05627115
What this trial is testing

Response Adapted Incorporation of Tislelizumab Into the Front-line Treatment of Older Patients With Hodgkin lYmphoma

Who this might be right for
Hodgkin Lymphoma
University College, London 80
Not applicableStudy completedNCT00014235
What this trial is testing

Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia/Transient Myeloproliferative DisorderAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+74 more
Fred Hutchinson Cancer Center 160
Early research (Phase 1)Study completedNCT01569815
What this trial is testing

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Who this might be right for
Mild and Moderate Renal Impairment
Novartis Pharmaceuticals 32
Testing effectiveness (Phase 2)Ended earlyNCT04504708
What this trial is testing

Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant or Refractory Advanced Hematologic Malignancies

Who this might be right for
Non-hodgkin LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Hangzhou Zenshine Pharmaceuticals Co., Ltd. 6
Early research (Phase 1)Study completedNCT00788684
What this trial is testing

Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers

Who this might be right for
CD20-Positive Lymphoid MalignanciesChronic Lymphoid LeukemiaHematological Malignancies+1 more
AbbVie 29
Testing effectiveness (Phase 2)Study completedNCT01212952
What this trial is testing

Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
Mayo Clinic 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03995147
What this trial is testing

Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma

Who this might be right for
B Cell LymphomaLymphomaLymphoma, B-Cell+2 more
University of Chicago 51
Testing effectiveness (Phase 2)Study completedNCT00869284
What this trial is testing

Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma
French Innovative Leukemia Organisation 45
Post-approval studies (Phase 4)Ended earlyNCT03959852
What this trial is testing

Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

Who this might be right for
Pain, Acute
Mercy Health Ohio 6
Not applicableLooking for participantsNCT06294652
What this trial is testing

AGMT Austrian Lymphoma Registry

Who this might be right for
Lymphoma
Arbeitsgemeinschaft medikamentoese Tumortherapie 4,000
Early research (Phase 1)Ended earlyNCT05065047
What this trial is testing

Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 6
Not applicableStudy completedNCT05212233
What this trial is testing

Financial Difficulty in Patients With Blood Cancer

Who this might be right for
Chronic Lymphocytic LeukemiaMultiple Myeloma
UNC Lineberger Comprehensive Cancer Center 218
Next Page